These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21792529)

  • 41. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW
    CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The comorbidity of diabetes mellitus and psychiatric disorders.
    Medved V; Jovanović N; Knapić VP
    Psychiatr Danub; 2009 Dec; 21(4):585-8. PubMed ID: 19935498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Body weight changes and psychotropic drug treatment: neuroleptics].
    Recasens C
    Encephale; 2001; 27(3):269-76. PubMed ID: 11488257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Managing weight gain and metabolic issues in patients treated with atypical antipsychotics.
    Henderson DC
    J Clin Psychiatry; 2008 Feb; 69(2):e04. PubMed ID: 18363448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Managing the side effects associated with commonly used treatments for bipolar depression.
    Kemp DE
    J Affect Disord; 2014 Dec; 169 Suppl 1():S34-44. PubMed ID: 25533913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prenatal antipsychotic exposure and neuromotor performance during infancy.
    Johnson KC; LaPrairie JL; Brennan PA; Stowe ZN; Newport DJ
    Arch Gen Psychiatry; 2012 Aug; 69(8):787-94. PubMed ID: 22474072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of psychotropic drugs on the regulation of glucose metabolism.
    Al-Zoairy R; Ress C; Tschoner A; Kaser S; Ebenbichler C
    Curr Diabetes Rev; 2013 Sep; 9(5):362-70. PubMed ID: 23845076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story?
    Correll CU
    J Clin Psychiatry; 2005 Oct; 66(10):1331-2. PubMed ID: 16259549
    [No Abstract]   [Full Text] [Related]  

  • 49. Independence of diabetes and obesity in adults with serious mental illness: Findings from a large urban public hospital.
    Sun L; Getz M; Daboul S; Jay M; Sherman S; Rogers E; Aujero N; Rosedale M; Goetz RR; Weissman J; Malaspina D; Ahmad S
    J Psychiatr Res; 2018 Apr; 99():159-166. PubMed ID: 29482065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Affective disorders and diabetes].
    Himmerich H; Pollmächer T; Schaaf L
    MMW Fortschr Med; 2006 Jun; 148(26):37-40. PubMed ID: 16875377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
    Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL
    J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of weight gain associated with antipsychotics.
    Birt J
    Ann Clin Psychiatry; 2003 Mar; 15(1):49-58. PubMed ID: 12839432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of antipsychotic medications on microbiome and weight gain in children and adolescents.
    Bretler T; Weisberg H; Koren O; Neuman H
    BMC Med; 2019 Jun; 17(1):112. PubMed ID: 31215494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1991 May; 33(844):43-50. PubMed ID: 1674103
    [No Abstract]   [Full Text] [Related]  

  • 56. Schizophrenia, antipsychotics and metabolic disease.
    Reynolds GP
    J Psychopharmacol; 2007 Jun; 21(4):355-6. PubMed ID: 17656424
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinically relevant drug interactions with new generation antidepressants and antipsychotics].
    Eckert A
    Ther Umsch; 2009 Jun; 66(6):485-92. PubMed ID: 19496045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methodological challenges in psychiatric treatment adherence research.
    Velligan D; Sajatovic M; Valenstein M; Riley WT; Safren S; Lewis-Fernandez R; Weiden P; Ogedegbe G; Jamison J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):74-91. PubMed ID: 20643631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychiatric medication-induced obesity: treatment options.
    Schwartz TL; Nihalani N; Virk S; Jindal S; Chilton M
    Obes Rev; 2004 Nov; 5(4):233-8. PubMed ID: 15458397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physical health management in psychiatric settings.
    De Hert M; van Winkel R; Silic A; Van Eyck D; Peuskens J
    Eur Psychiatry; 2010 Jun; 25 Suppl 2():S22-8. PubMed ID: 20620882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.